Neonatal Fc Receptor–Targeted Therapies in Neurology

Autoantibodies are increasingly recognized for their pathogenic potential in a growing number of neurological diseases. While myasthenia gravis represents the prototypic antibody (Ab)-mediated neurological disease, many more disorders characterized by Abs targeting neuronal or glial antigens have be...

Descripción completa

Detalles Bibliográficos
Autores principales: Nelke, Christopher, Spatola, Marianna, Schroeter, Christina B., Wiendl, Heinz, Lünemann, Jan D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9294083/
https://www.ncbi.nlm.nih.gov/pubmed/34997443
http://dx.doi.org/10.1007/s13311-021-01175-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9294083/
https://www.ncbi.nlm.nih.gov/pubmed/34997443
http://dx.doi.org/10.1007/s13311-021-01175-7

Ejemplares similares